BCG may safely and significantly lower blood sugar in type 1 diabetes: Clinical trial Dr Kartikeya Kohli26 Jun 2021 9:15 AM ISTBOSTON - BCG (Bacillus Calmette-Guérin) is an old vaccine which is used for prevention of tuberculosis. Besides this it has been used for standard of...
RedHill oral pill Opaganib shows promise against Covid-related pneumonia Medical Dialogues Team23 Jun 2021 11:57 AM ISTTel Aviv: Israel-based biopharmaceutical company RedHill Biopharma's new oral pill called Opaganib has been found effective in patients hospitalised...
Increased serum magnesium lowers risk of intracranial aneurysm: Study Dr. Shravani Dali22 Jun 2021 4:49 PM ISTHigher serum magnesium levels could reduce the risk of intracranial aneurysm and the associated aneurysmal subarachnoid hemorrhage, suggests a study...
Include cardiology parameters in clinical trial of anti diabetic drug Lobeglitazone: CDSCO panel tells Glenmark Medical Dialogues Team22 Jun 2021 2:54 PM ISTNew Delhi: In accordance with the proposal presented by pharma major, Glenmark, on the anti-diabetic drug molecule, Lobeglitazone Sulphate Tablets,...
Doxycycline with standard treatment accelerates recovery in TB: Clinical Trial Dr. Kamal Kant Kohli21 Jun 2021 10:30 AM ISTResearchers at NUS Yong Loo Lin School of Medicine's Infectious Diseases Translational Research Programme have found in a Phase 2 double-blind tria...
DCGI nod to CSIR-Laxai Colchicine trials in Covid-19 patients Ruchika Sharma12 Jun 2021 11:00 AM ISTNew Delhi: Laxai Life Sciences, Hyderabad, and Council of Scientific & Industrial Research (CSIR), have been given the regulatory approval by...
CDSCO panel nod to Zydus antibodies cocktail trials to treat COVID Ruchika Sharma5 Jun 2021 1:03 PM ISTZydus said that its biological therapy ZRC-3308, a cocktail of two SARS-CoV-2-neutralising monoclonal antibodies (mAbs) can emerge as one of the main...
DCGI exempts foreign-made COVID vaccines from post-approval bridging trials Medical Dialogues Team2 Jun 2021 4:29 PM ISTNew Delhi: Through a recent notification, the Central Drugs Standards Control Organization (CDSCO), led by the Drugs Controller General of India...
MSN Labs begins COVID drug Molnupiravir phase III trial Ruchika Sharma26 May 2021 12:23 PM ISTMolnupiravir is an experimental drug having antiviral properties and is currently under clinical-stage study for COVID treatment.
COVID-19: Natco Pharma begins Molnupiravir capsules Phase III trial in India Ruchika Sharma23 May 2021 9:45 AM ISTHyderabad: Drug major, Natco Pharma Limited, has initiated Phase-III clinical trial of Molnupiravir capsules in India. Its first patient was...
DCGI nod to Optimus Pharma Molnupiravir Phase 3 trials on COVID patients Ruchika Sharma20 May 2021 2:00 PM ISTHyderabad: Drugs Manufacturer from Hyderabad, Optimus Pharma on Wednesday said it has received Drugs Controller General of India (DCGI) nod for...
Delhi HC seeks Centre reply on PIL against Covaxin trial on 2-18 age group Ruchika Sharma20 May 2021 10:00 AM ISTKumar, in his plea, has raised an apprehension that the children who would be part of the trial could suffer adverse health or mental effects due to...
